Cutaneous reactions to recombinant cytokine therapy
Authors:
- Anthony A GaspariAGAnthony A Gaspari
Open Access
- 1 September 1995
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 33 (3) , 393-410
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum.Journal of Clinical Investigation, 1993
- Transient acantholytic dermatosis induced by recombinant human interleukin 4Journal of the American Academy of Dermatology, 1993
- The cytokine wall chartImmunology Today, 1993
- Cutaneous side effects associated with interleukin 2 administration for metastatic melanomaJournal of the American Academy of Dermatology, 1993
- Systemic lupus erythematosus in a child receiving long-term interferon therapyThe Journal of Pediatrics, 1992
- Pustular eruption at the site of subcutaneous injection of recombinant human granulocyte-macrophage colony-stimulating factorAnnals of Hematology, 1991
- The pathogenesis of Sweet's syndromeJournal of the American Academy of Dermatology, 1991
- Therapeutic use of cytokines in dermatologyJournal of the American Academy of Dermatology, 1991
- DIFFERENTIAL EFFECT OF G‐CSF AND GM‐CSF IN ACQUIRED CHRONIC NEUTROPENIABritish Journal of Haematology, 1991
- Colony-stimulating factorsJournal of the American Academy of Dermatology, 1990